238 related articles for article (PubMed ID: 31690954)
21. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
22. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.
Nakano H; Kirino Y; Takeno M; Higashitani K; Nagai H; Yoshimi R; Yamaguchi Y; Kato I; Aoki I; Nakajima H
Arthritis Res Ther; 2018 Jun; 20(1):124. PubMed ID: 29895319
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
24. Detection of M2-macrophages in uveal melanoma and relation with survival.
Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
[TBL] [Abstract][Full Text] [Related]
25. Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3.
Wang X; Zhang L; Zhou Y; Wang Y; Wang X; Zhang Y; Quan A; Mao Y; Zhang Y; Qi J; Ren Z; Gu L; Yu R; Zhou X
Cancer Immunol Res; 2024 May; 12(5):516-529. PubMed ID: 38437646
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
[TBL] [Abstract][Full Text] [Related]
27. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
Taubert H; Eckstein M; Epple E; Jung R; Weigelt K; Lieb V; Sikic D; Stöhr R; Geppert C; Weyerer V; Bertz S; Kehlen A; Hartmann A; Wullich B; Wach S
Cells; 2021 Jan; 10(1):. PubMed ID: 33467469
[TBL] [Abstract][Full Text] [Related]
28. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
[TBL] [Abstract][Full Text] [Related]
29. PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages.
Zhu Z; Zhang H; Chen B; Liu X; Zhang S; Zong Z; Gao M
Front Immunol; 2020; 11():588552. PubMed ID: 33329573
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.
Komohara Y; Ohnishi K; Kuratsu J; Takeya M
J Pathol; 2008 Sep; 216(1):15-24. PubMed ID: 18553315
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
32. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages.
Barros MH; Hauck F; Dreyer JH; Kempkes B; Niedobitek G
PLoS One; 2013; 8(11):e80908. PubMed ID: 24260507
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patients.
Kemmerer CL; Schittenhelm J; Dubois E; Neumann L; Häsler LM; Lambert M; Renovanz M; Kaeser SA; Tabatabai G; Ziemann U; Naumann U; Kowarik MC
BMC Cancer; 2021 Oct; 21(1):1108. PubMed ID: 34654395
[TBL] [Abstract][Full Text] [Related]
34. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
[TBL] [Abstract][Full Text] [Related]
35. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
36. Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity.
Tsuda S; Carreras J; Kikuti YY; Nakae H; Dekiden-Monma M; Imai J; Tsuruya K; Nakamura J; Tsukune Y; Uchida T; Matsushima M; Roncador G; Suzuki T; Nakamura N; Mine T
Pathol Int; 2019 May; 69(5):260-271. PubMed ID: 30990953
[TBL] [Abstract][Full Text] [Related]
37. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
38. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.
Zhang L; Xu Y; Sun J; Chen W; Zhao L; Ma C; Wang Q; Sun J; Huang B; Zhang Y; Li X; Qu X
Oncotarget; 2017 Jan; 8(1):819-832. PubMed ID: 27903982
[TBL] [Abstract][Full Text] [Related]
39. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.
Cornelissen R; Lievense LA; Maat AP; Hendriks RW; Hoogsteden HC; Bogers AJ; Hegmans JP; Aerts JG
PLoS One; 2014; 9(9):e106742. PubMed ID: 25192022
[TBL] [Abstract][Full Text] [Related]
40. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]